BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6598493)

  • 21. Preparation of new [1,2,4]triazolo[4,3-b]pyridazines. Part 12: Studies in the field of pyridazine compounds.
    Kosáry J; Kasztreiner E; Lázár A; Sóti M
    Pharmazie; 1983 Jun; 38(6):369-71. PubMed ID: 6611639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on antiatherosclerotic agents. Synthesis and inhibitory activities on platelet aggregation of 4-aryl derivatives of 7-ethoxycarbonyl-6,8-dimethyl-1 (2H)-phthalazinone.
    Eguchi Y; Sato Y; Sekizaki S; Ishikawa M
    Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):2009-15. PubMed ID: 1797422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and antihypertensive properties of some dopamino-pyridazin-3(2H)-one derivatives.
    Corsano S; Strappaghetti G; Scapicchi R
    Arch Pharm (Weinheim); 1992 Mar; 325(3):187-91. PubMed ID: 1642515
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis and pharmacological evaluation of 4a-methyl-4,4a,5,6-tetrahydrothieno[2,3-h]cinnolin-3(2H)-ones.
    Pinna GA; Salis E; Berta D; Gavini E; D'Amico M
    Farmaco; 1997 Jan; 52(1):29-33. PubMed ID: 9181678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and hypotensive activity of some heterocyclic analogues of GYKI-12 743.
    Mátyus P; Kasztreiner E; Diesler E; Behr A; Varga I; Kosáry J; Rabloczky G; Jaszlits L
    Arch Pharm (Weinheim); 1994 Sep; 327(9):543-6. PubMed ID: 7979923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperreactive arterial endothelial cells in atherogenesis. Effect of smooth muscle relaxants.
    Shimamoto T; Moriya K; Kobayashi DV; Takahashi T; Numano F
    Adv Exp Med Biol; 1977; 82():234-6. PubMed ID: 920366
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on antiatherosclerotic agents. Synthesis of 7-ethoxycarbonyl-4-formyl-6,8-dimethyl-1(2H)-phthalazinone derivatives and related compounds.
    Eguchi Y; Sasaki F; Takashima Y; Nakajima M; Ishikawa M
    Chem Pharm Bull (Tokyo); 1991 Mar; 39(3):795-7. PubMed ID: 2070467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and pharmacological evaluation of 4,4a,5,6-tetrahydro-7,8-disubstituted-benzo[h]cinnolin-3(2H)-ones.
    Pinna GA; Loriga M; Curzu MM; D'Amico M
    Farmaco; 1997 Jan; 52(1):25-8. PubMed ID: 9181677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diftalone. Synthesis and chemical behaviour of its metabolic products.
    Bellasio E; Martinelli E; Nathansohn G
    Farmaco Sci; 1975 Jun; 30(6):425-39. PubMed ID: 1140380
    [No Abstract]   [Full Text] [Related]  

  • 30. Synthesis and structure-activity relationships of cis-tetrahydrophthalazinone/pyridazinone hybrids: a novel series of potent dual PDE3/PDE4 inhibitory agents.
    Van der Mey M; Bommelé KM; Boss H; Hatzelmann A; Van Slingerland M; Sterk GJ; Timmerman H
    J Med Chem; 2003 May; 46(10):2008-16. PubMed ID: 12723963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of EG-1088, EG-626 and nifedipine on vascular lesions associated with hypertension and hyperlipidemia in stroke-prone spontaneously hypertensive rats (SHR-SP)].
    Kobayashi M; Moriya K; Eguchi Y; Sugimoto A; Ito S; Ishikawa M
    Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1984; 18():25-38. PubMed ID: 6598494
    [No Abstract]   [Full Text] [Related]  

  • 32. 3,6-Bis(2-pyridyl)di-1,2,4-triazolo[3,4-a:4',3'-c]phthalazine.
    Chang WF; Wen YS; Liu LK
    Acta Crystallogr C; 2004 Sep; 60(Pt 9):o665-7. PubMed ID: 15345850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological properties of pyrido [2, 3-d] pyridazine derivatives.
    Kuczyński L; Mrozikiewicz A; Banaszkiewicz W; Respond S
    Pol J Pharmacol Pharm; 1982; 34(4):223-8. PubMed ID: 7182843
    [No Abstract]   [Full Text] [Related]  

  • 34. Fate of hydralazine in man. II. Formation of tetrazolo[5,1-a]phthalazine in vivo and inhibition of monoamine oxidase by this metabolite.
    Noda A; Noda H; Minemoto M; Zaitsu K; Ohkura Y; Iguchi S
    Chem Pharm Bull (Tokyo); 1981 Sep; 29(9):2683-5. PubMed ID: 7349285
    [No Abstract]   [Full Text] [Related]  

  • 35. Endralazine and sexual arousal.
    Zacest R; Reece PA
    Lancet; 1983 May; 1(8335):1221. PubMed ID: 6134016
    [No Abstract]   [Full Text] [Related]  

  • 36. Demonstration of the potassium channel opening activity of GYKI-12743 by 86Rb+ efflux studies.
    Bakonyi A; Horváth EJ
    Acta Physiol Hung; 1994; 82(4):295-300. PubMed ID: 7785439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Synthesis of 4-phenyl and 4-benzyl substituted phthalazinone and its derivatives].
    Eguchi Y; Hasegawa Y; Ishikawa M
    Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1988; 22():47-52. PubMed ID: 3255117
    [No Abstract]   [Full Text] [Related]  

  • 38. [Synthesis of 5-aminophthalazine derivates (author's transl)].
    Watanabe T; Hamaguchi F; Ohki S
    Yakugaku Zasshi; 1976 Jun; 96(6):721-4. PubMed ID: 987206
    [No Abstract]   [Full Text] [Related]  

  • 39. [New derivatives of 1-methyl-phthalazine with antimicrobial and fungistatic action].
    Dima S; Caprosu M; Ungureanu M; Grosu G; Petrovanu M
    Ann Pharm Fr; 1999 Sep; 57(5):415-6. PubMed ID: 10520515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Synthesis and pharmacologic selection of new antihypertensive agents].
    Boschetti E; Grand M; Molho D; Fontaine L
    Therapie; 1968; 23(5):1221-32. PubMed ID: 5703937
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.